JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ogletree, M. L.
Right arrow Articles by Lefer, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ogletree, M. L.
Right arrow Articles by Lefer, A. M.

Influence of nonsteroidal anti-inflammatory agents on myocardial ischemia in the cat

ML Ogletree and AM Lefer

Indomethacin, meclofenamic acid and acetylsalicylic acid are prostaglandin synthetase-inhibiting, nonsteroidal anti-inflammatory drugs. Their effects on hemodynamic and enzymatic responses to coronary artery occlusion were evaluated in the cat. The direct effects of these drugs on isolated tissue preparations (i.e., cat papillary muscle, aortic strip and liver lysosomes) were also studied. None of the drugs tested exhibited any significant hemodynamic or biochemical effects which would indicate protection against damage due to myocardial ischemia during the 5-hour experimental period. Furthermore, only indomethacin produced significant effects on the isolated tissues studied. Indomethacin increased the tension of aortic strips confirming a pressor effect seen in the intact animal and exerted a modest stabilization of isolated liver lysosomes. All three anti-inflammatory drugs inhibited prostaglandin F2alpha, release in heart homogenates by 82 to 87%. It is concluded that nonsteroidal anti-inflammatory drugs do not significantly influence the early course of myocardial ischemia in the cat, in contrast to the previously reported preservation of myocardial integrity afforded by dexamethasone and methylprednisolone.

Volume 197, Issue 3, pp. 582-593, 06/01/1976
Copyright © 1976 by American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics.